Majdi Al-Hasan to Treatment Outcome
This is a "connection" page, showing publications Majdi Al-Hasan has written about Treatment Outcome.
Connection Strength
0.467
-
Use of Antibiotics in Chronic Obstructive Pulmonary Disease: What is Their Current Role in Older Patients? Drugs Aging. 2020 09; 37(9):627-633.
Score: 0.079
-
Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections. Clin Microbiol Infect. 2020 Mar; 26(3):299-306.
Score: 0.072
-
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
Score: 0.064
-
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
Score: 0.058
-
Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
Score: 0.052
-
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscesses. Am J Med Sci. 2013 Oct; 346(4):341-4.
Score: 0.049
-
Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011 May; 66(5):1156-60.
Score: 0.041
-
Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010 Feb; 85(2):139-44.
Score: 0.038
-
Comparison of ?-lactam plus aminoglycoside versus ?-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli. J Chemother. 2017 Feb; 29(1):30-37.
Score: 0.015